1.
Accelerating measles elimination and strengthening routine immunization services in Guizhou Province, China, 2003–2009
by Zuo, Shuyan
Vaccine, 2015, Vol.33 (17), p.2050-2055
2.
A dangerous measles future looms beyond the COVID-19 pandemic
by Durrheim, David N
Nature medicine, 2021, Vol.27 (3), p.360-361
4.
The dynamics of measles in sub-Saharan Africa
by Ferrari, Matthew J
Nature, 2008, Vol.451 (7179), p.679-684
5.
Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data
by Chandir, Subhash
Vaccine, 2020, Vol.38 (45), p.7146-7155
6.
Low percentages of measles vaccination coverage with two doses of vaccine and low herd immunity levels explain measles incidence and persistence of measles in the European Union in...
by Plans-Rubió, Pedro
European journal of clinical microbiology & infectious diseases, 2019, Vol.38 (9), p.1719-1729
7.
Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine
by Seagle, Emma E
Vaccine, 2018, Vol.36 (6), p.818-826
8.
Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data
by Simons, Emily, MPH
The Lancet (British edition), 2012, Vol.379 (9832), p.2173-2178
9.
Comparison of neutralizing antibody titers against outbreak-associated measles genotypes (D4, H1 and B3) in Iran
by Fatemi Nasab, Ghazal Sadat
Pathogens and disease, 2016, Vol.74 (8), p.ftw089
10.
A global perspective of vaccination of healthcare personnel against measles: Systematic review
by Fiebelkorn, Amy Parker
Vaccine, 2013, Vol.32 (38), p.4823-4839
11.
12.
13.
High resolution age-structured mapping of childhood vaccination coverage in low and middle income countries
by Utazi, C. Edson
Vaccine, 2018, Vol.36 (12), p.1583-1591
14.
15.
An increasing, potentially measles-susceptible population over time after vaccination in Korea
by Kang, Hae Ji
Vaccine, 2017, Vol.35 (33), p.4126-4132
16.
17.
Measles in Europe: an epidemiological assessment
by Muscat, Mark, Dr
The Lancet (British edition), 2009, Vol.373 (9661), p.383-389
18.
Measles immunity in emergency medical providers
by Gongola, AlleaBelle
Vaccine, 2020, Vol.38 (41), p.6350-6351
19.
The effect of heterogeneity in uptake of the measles, mumps, and rubella vaccine on the potential for outbreaks of measles: a modelling study
by Glasser, John W, Dr
The Lancet infectious diseases, 2016, Vol.16 (5), p.599-605
20.
Using data to improve outcomes of supplemental immunisation activities: 2017/2018 Nigeria measles vaccination campaign
by Mogekwu, Fred Ikechukwu
Vaccine, 2021, Vol.39, p.C38-C45
